Bausch & Lomb Incorporated
Clinical trials sponsored by Bausch & Lomb Incorporated, explained in plain language.
An eye health company selling contact lenses, pharmaceuticals, and surgical products.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New eye drops aim to ease pain after laser surgery
Symptom relief Not yet recruitingThis Phase 2 trial tests whether BL1332 eye drops can reduce pain after PRK laser eye surgery. About 123 adults will receive either a low or high dose of the drops or a placebo, applied five times a day. The study is double-masked, meaning neither patients nor doctors know who ge…
Phase: PHASE2 • Sponsor: Bausch & Lomb Incorporated • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
New laser aims to sharpen vision for mild nearsightedness
Symptom relief Not yet recruitingThis study tests a new excimer laser for LASIK surgery to correct mild nearsightedness (up to -1.00 diopter) with or without astigmatism. About 32 adults aged 22 and older will receive the treatment in one or both eyes. The goal is to see if the laser safely and accurately improv…
Phase: NA • Sponsor: Bausch & Lomb Incorporated • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New custom contact lenses tested for astigmatism
Knowledge-focused Not yet recruitingThis study looks at how well REVIVE samfilcon B custom toric contact lenses work for people with astigmatism. About 30 adults will wear the lenses, and eye doctors will rate their satisfaction after 14 days. The goal is to see if these lenses provide clear vision and are easy to …
Sponsor: Bausch & Lomb Incorporated • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC